Stopping antihypertensive Treatment amOng hypertensive patients in Primary care: the STOP-Trial - Top-Institutions - MDSpire

Stopping antihypertensive Treatment amOng hypertensive patients in Primary care: the STOP-Trial

By
Jean-Marc Boivin
Joao Pedro Ferreira
Marilucy Lopez-Sublet
Kevin Duarte
Faiez Zannad
Patrick Rossignol
Nicolas Girerd
August 21, 2025
0 min

European Journal Of Preventive Cardiology

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

#1

Mayo Clinic

Rochester, MN
Key Differentiators
- Hypertension
- Cardiology
- Clinical Research
#2

Johns Hopkins University

Baltimore, MD
Key Differentiators
- Hypertension
- Cardiology
- Epidemiology
#3

Cleveland Clinic

Cleveland, OH
Key Differentiators
- Cardiology
- Hypertension
- Internal Medicine
#4

Brigham and Women's Hospital

Boston, MA
Key Differentiators
- Cardiology
- Hypertension
- Clinical Trials
#5

University of Oxford

Oxford, UK
Key Differentiators
- Hypertension
- Cardiovascular Medicine
- Clinical Epidemiology

Original Source(s)

European Journal Of Preventive Cardiology

Stopping antihypertensive Treatment amOng hypertensive patients in Primary care: the STOP-Trial

by Jean-Marc Boivin, Joao Pedro Ferreira, Marilucy Lopez-Sublet, Kevin Duarte, Faiez Zannad, Patrick Rossignol, Nicolas Girerd
August 21, 2025

Related Content

Frontiers In Endocrinology

Serum uric acid levels and cardiorenal complication prevalence in hypertensive patients before and after the COVID-19 pandemic: a retrospective cross-sectional study from a tertiary traditional Chinese medicine hospital

Frontiers In Cardiovascular Medicine

Cardiovascular disease risk and associated factors among people with hypertension in the West Bank, Palestine

Conexiant

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

by Kathryn Wighton
May 29, 2026
3 min